We conducted a cohort study to examine the association between anticholinergic use and CVEs in a cohort with newly diagnosed COPD. In our study, we found an increased risk of CVE associated with the ...
The drug ipratropium bromide (Atrovent, Combivent) significantly raised the risk of mortality by cardiovascular death in patients undergoing COPD treatment, according to researchers. In addition, ...
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Compared with ipratropium alone, fluticasone/salmeterol combination therapy resulted in better clinical outcomes and similar or lower treatment costs in all COPD ...
Jan. 8 -- THURSDAY, Jan. 7 (HealthDay News) -- New research suggests that the drug ipratropium bromide (Atrovent), used widely among patients who have chronic obstructive pulmonary disease (COPD), may ...
Active ingredients of dual-action Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol now delivered by new propellant-free inhaler RIDGEFIELD, Conn., Oct. 10, 2011 /PRNewswire/ - ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Atrovent MDI? Atrovent metered dose inhaler ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. 1. Why am I using Atrovent Inhalation Solution? Atrovent Inhalation ...
Background: Studies have suggested an increased risk of cardiovascular morbidity and mortality associated with the use of ipratropium bromide. We sought to examine the association between ipratropium ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback